Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of allogeneic human liver stem cells in pediatric early-onset urea cycle disorder
2022-000933-18Phase 2Completed
- Sponsor
- Unicyte
- Start
- Apr 2022
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of HLSC-001 in urea cycle disorder (UCD), sponsored by Unicyte. Started Apr 2022; status: completed.
02
Drugs
HLSC-001
03
Conditions
urea cycle disorder (UCD)
Beyond the preview
Go deeper on 2022-000933-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-000933-18.